Tag:
A/H5N1
Latest Headlines
Latest Headlines
Bird flu vaccine hits the clinic
Novavax saw a climb in its share value on the announcement that it has started enrollment of a Phase I clinical trial of its A/H5N1 vaccine to prevent bird flu.
THE LIBRARY: WEBINAR
When Efficacy Isn't Enough: Integrating Product Commercialization Strategy into Clinical and Regulatory Planning
Undertaking commercialization strategy and planning from early stages of development can ensure that considerable R&D investment results in successful market and patient access. Join HERON, a PAREXEL Company, in a timely webinar that addresses best practice commercialization planning. Register to watch now!
EVENTS
- Partnership Opportunities in Drug Delivery October 14-15, 2014 — Sponsored by: The Conference Forum
- BioBasics: Biotech for the Non-ScientistOctober 23-24 — Boston, MA
- Leveraging Metabolite Biomarkers for Clinical TrialsThursday, October 30th, 11 am ET / 8 am PT — Presented by: Metabolon
Press Releases
- Consort Medical plc announces the proposed acquisition of Aesica Pharmaceuticals Limited for £230 million
- GSK appoints Mr Urs Rohner to its Board as a Non-Executive Director
- Medtronic Announces Updated Financing Plans for Covidien Acquisition
- D&A PHARMA signs licensing and distribution agreement with Grupo JUSTE for ALCOVER® in SPAIN and Central America
- Nordson Snags Avalon Laboratories For $180 Million
- More Press Releases
Sponsored Links